Mylan featured on Nasdaq 100

PITTSBURGH The list of the top 100 companies traded on Nasdaq now includes a generic drug maker.

Mylan announced Monday that it had been listed on the Nasdaq-100, which consists of the securities of the 100 companies considered the largest and most innovative outside the financial sector and includes companies from the pharmaceutical, biotech, computer hardware, retail and other industries.

Mylan’s listing goes into effect on Dec. 21, and its shares will also be included in Nasdaq’s PowerShares QQQ.

“We are extremely pleased to join Nasdaq’s most widely followed index of leading companies,” Mylan chairman and CEO Robert Coury stated. “This development marks yet another significant milestone for Mylan and reflects the rapid growth and strong potential of our highly integrated and diversified global pharmaceuticals platform.”